|
Volumn 23, Issue 4, 2008, Pages 912-918
|
Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GELATINASE B;
INTERSTITIAL COLLAGENASE;
MATRIX METALLOPROTEINASE 14;
MMP1 PROTEIN, HUMAN;
STROMELYSIN;
TISSUE INHIBITOR OF METALLOPROTEINASE;
TISSUE INHIBITOR OF METALLOPROTEINASE 1;
TISSUE INHIBITOR OF METALLOPROTEINASE 4;
TISSUE INHIBITOR OF METALLOPROTEINASE-4;
VASCULOTROPIN A;
ADULT;
ARTICLE;
AUSTRALIA;
COMPARATIVE STUDY;
DRUG EFFECT;
ENDOMETRIUM;
FEMALE;
GENE EXPRESSION;
HORMONE SUBSTITUTION;
HUMAN;
METABOLISM;
METRORRHAGIA;
MIDDLE AGED;
NEEDLE BIOPSY;
PATHOLOGY;
POSTMENOPAUSE;
PROSPECTIVE STUDY;
VASCULARIZATION;
ADULT;
AUSTRALIA;
BIOPSY, NEEDLE;
ENDOMETRIUM;
FEMALE;
GENE EXPRESSION;
HORMONE REPLACEMENT THERAPY;
HUMANS;
MATRIX METALLOPROTEINASE 1;
MATRIX METALLOPROTEINASE 14;
MATRIX METALLOPROTEINASE 3;
MATRIX METALLOPROTEINASE 9;
METRORRHAGIA;
MIDDLE AGED;
POSTMENOPAUSE;
PROSPECTIVE STUDIES;
TISSUE INHIBITOR OF METALLOPROTEINASE-1;
TISSUE INHIBITOR OF METALLOPROTEINASES;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 44249092150
PISSN: None
EISSN: 14602350
Source Type: Journal
DOI: 10.1093/humrep/dem418 Document Type: Article |
Times cited : (6)
|
References (0)
|